Found: 24
Select item for more details and to access through your institution.
Struggling for peace, struggling for justice: The 2021 Peace History Society conference issue.
- Published in:
- 2023
- By:
- Publication type:
- Proceeding
Teaching histories of peace and justice: A roundtable.
- Published in:
- Peace & Change, 2023, v. 48, n. 2, p. 117, doi. 10.1111/pech.12613
- By:
- Publication type:
- Article
A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofz035
- By:
- Publication type:
- Article
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1835, doi. 10.3390/pharmaceutics15071835
- By:
- Publication type:
- Article
Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-023-00514-2
- By:
- Publication type:
- Article
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39158-1
- By:
- Publication type:
- Article
Physical Activity in Older Adults With Visual Impairment.
- Published in:
- American Journal of Occupational Therapy, 2021, v. 75, p. 1, doi. 10.5014/ajot.2021.75S2-RP130
- By:
- Publication type:
- Article
Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 4, p. 2078, doi. 10.1111/bcp.14619
- By:
- Publication type:
- Article
The role of drug transporters in the kidney: lessons from tenofovir.
- Published in:
- Frontiers in Pharmacology, 2014, v. 5, p. 1, doi. 10.3389/fphar.2014.00248
- By:
- Publication type:
- Article
Chemoprophylactic Assessment of Combined Intranasal SARS-CoV-2 Polymerase and Exonuclease Inhibition in Syrian Golden Hamsters.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 11, p. 2161, doi. 10.3390/v15112161
- By:
- Publication type:
- Article
Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 8, p. 1744, doi. 10.3390/v15081744
- By:
- Publication type:
- Article
Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus–Infected Individuals.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 3, p. 446, doi. 10.1093/cid/ciy491
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 5, p. 785, doi. 10.1093/cid/ciy161
- By:
- Publication type:
- Article
Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 775, doi. 10.1002/cpt.1909
- By:
- Publication type:
- Article
Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S490, doi. 10.1093/cid/ciac685
- By:
- Publication type:
- Article
NIRMATRELVIR AND MOLNUPIRAVIR COADMINISTRATION MODIFIES PRECLINICAL VIRAL EXPOSURE.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 218
- By:
- Publication type:
- Article
NAFAMOSTAT AS NASAL CHEMOPROPHYLAXIS FOR SARS-CoV-2 IN HAMSTERS.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 217
- By:
- Publication type:
- Article
Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2334, doi. 10.1093/jac/dkae232
- By:
- Publication type:
- Article
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 1, p. 172, doi. 10.1093/jac/dkad362
- By:
- Publication type:
- Article
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Meta-analysis of the effect of CYP2B6, CYP2A6, UGT2B7 and CAR polymorphisms on efavirenz plasma concentrations.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, n. 11, p. 3281, doi. 10.1093/jac/dkz329
- By:
- Publication type:
- Article
Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Meta-analysis of the effect of CYP2B6, CYP2A6, UGT2B7 and CAR polymorphisms on efavirenz plasma concentrations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide.
- Published in:
- 2019
- By:
- Publication type:
- journal article